Today’s feature is posted with permission from HealthTech magazine.
Emerging technology, such as the cloud, help to push the boundaries of genomics, viral surveillance & other biomolecular medicine, says the director of the National Center for Biotechnology Information.
Biotechnology—which harnesses cellular or biomolecular processes to improve care—is helping healthcare reach new heights as book collaboration & computational flexibility expand the tech’s reach. This is according to James M. Ostell, director of the National Center for Biotechnology Information (NCBI), a division of the National Library of Medicine at the National Institutes of Health.
Dr. James Ostell, NCBI Director (Photo by Jessica Marcotte. Illustration by Donald Bliss, NLM.)
Although he only stepped in as director last September, Ostell has a long history with NCBI, having been at the organization since it was established by Congress in 1988. Since then, he has helped to shape it into one of the most widely used biomedical resources in the world.
Four million users a day access NCBI’s resources, which include major biomedical databases, such as the literature database PubMed and GenBank for DNA sequences. The organization also offers an array of computational & analysis tools related to genes’ role in health and disease.
With an eye on biotechnology’s future, Ostell offers insights on where the technology stands, and what it might help the healthcare industry achieve in the future.
HEALTHTECH: What is the mission of the National Center for Biotechnology Information?
OSTELL: Originally, the NCBI focused on basic research & algorithm development as well as developing resources, training and providing resources to the…